Jakafi 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DR26FSQN1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,523
Award facts
- Contract value 100% obligated
- $49,522.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $49.5K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of JAKAFI 5 MG. The award, issued on November 13, 2025, with an ultimate completion date of November 14, 2025, represents a firm fixed-price delivery order with no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $500M ceiling value and extends through December 31, 2036.
DMS Pharmaceutical Group's PPV-G GEN V contract, awarded on the same date, positions the company as a regional prime vendor contractor within the $30.3 billion acquisition strategy designed to supply a comprehensive range of pharmaceutical products to Department of Defense healthcare facilities worldwide. The contractor's established performance across multiple therapeutic categories—including oncology treatments, specialty pharmaceuticals, biologics, vaccines, and routine medications—supports its role as a critical supplier within the federal military medical supply chain. As a SAM-registered small business since 2001 with substantial prior federal contracting experience, DMS Pharmaceutical Group demonstrates the operational capability required to fulfill diverse and specialized pharmaceutical requirements across global military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FSQN1?
SPE2DR26FSQN1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26FSQN1 worth?
The government has obligated $49,523 on SPE2DR26FSQN1.
Is contract SPE2DR26FSQN1 an order under another contract?
Yes. SPE2DR26FSQN1 is a delivery order under SPE2DR25D9348, an indefinite delivery contract.
Was contract SPE2DR26FSQN1 competed?
The extent of competition for SPE2DR26FSQN1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award